triethylenemelamine has been researched along with Hematologic Diseases in 6 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
COLARUSSO, A | 1 |
PAVLOVSKY, A | 1 |
VILASECA, GC | 1 |
PREISLER, O | 1 |
D ERAMO, N | 1 |
VAN DER HEIDE-WESSEL, C | 1 |
GROEN, J | 1 |
Saslaw, S | 1 |
Carlisle, HN | 1 |
6 other studies available for triethylenemelamine and Hematologic Diseases
Article | Year |
---|---|
[Triethylene melamine in the treatment of certain blood diseases].
Topics: Hematologic Diseases; Hodgkin Disease; Leukemia; Triethylenemelamine | 1952 |
[Triethylene melanine in the treatment of certain blood diseases].
Topics: Hematologic Diseases; Melanins; Triethylenemelamine | 1953 |
[TREATMENT OF RH SENSITIZATION IN PREGNANCY].
Topics: Adrenocorticotropic Hormone; Chloroquine; Cortisone; Erythroblastosis, Fetal; Female; gamma-Globulin | 1963 |
[ON CLINICALLY PRIMARY PLEURITIS IN SYSTEMIC BLOOD DISEASES: OBSERVATION OF 2 CASES].
Topics: Adrenocorticotropic Hormone; Biopsy; Geriatrics; Hematologic Diseases; Hodgkin Disease; Humans; Mort | 1964 |
[Oral triethylene melamine therapy of malignant lymphogranuloma and related conditions].
Topics: Hematologic Diseases; Hodgkin Disease; Lymphatic System; Neoplasms; Triethylenemelamine | 1951 |
Nonhuman primates in evaluation of hematotoxicity.
Topics: Animals; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug-Related Side Effects and Adver | 1969 |